Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Jiangsu Aidea Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥3.56 Million ≈ $521.57K USD) by net assets (CN¥1.08 Billion ≈ $158.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)

Cash flow conversion efficiency of Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2025. This chart illustrates how Jiangsu Aidea Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Jiangsu Aidea Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.

Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Jiangsu Aidea Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jiangsu Aidea Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Aidea Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Jiangsu Aidea Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Thanh Thanh Cong Tay Ninh JSC VN:SBT	0.001x
Zhang Jia Jie Tourism Group Co Ltd SHE:000430	0.022x
MorningStar Partners, L.P. NYSE:TXO	0.040x
Chengdu Guibao Science Tech SHE:300019	0.079x
Bioventus Inc NASDAQ:BVS	0.072x
JBG SMITH Properties NYSE:JBGS	0.002x
PSI Software AG F:PSAN	-0.030x
Paul Hartmann AG F:PHH2	0.021x

Annual Cash Flow Conversion Efficiency for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2025. Review Jiangsu Aidea Pharmaceutical Co Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.07 Billion ≈ $157.05 Million	CN¥17.63 Million ≈ $2.58 Million	0.016x	+146.75%
2024-12-31	CN¥1.07 Billion ≈ $156.15 Million	CN¥-37.50 Million ≈ $-5.49 Million	-0.035x	+76.21%
2023-12-31	CN¥1.13 Billion ≈ $164.70 Million	CN¥-166.22 Million ≈ $-24.32 Million	-0.148x	-91.31%
2022-12-31	CN¥1.20 Billion ≈ $175.45 Million	CN¥-92.55 Million ≈ $-13.54 Million	-0.077x	-717.31%
2021-12-31	CN¥1.31 Billion ≈ $191.66 Million	CN¥-12.37 Million ≈ $-1.81 Million	-0.009x	-122.87%
2020-12-31	CN¥1.36 Billion ≈ $198.99 Million	CN¥56.17 Million ≈ $8.22 Million	0.041x	-59.12%
2019-12-31	CN¥556.24 Million ≈ $81.39 Million	CN¥56.20 Million ≈ $8.22 Million	0.101x	+257.64%
2018-12-31	CN¥522.71 Million ≈ $76.49 Million	CN¥-33.50 Million ≈ $-4.90 Million	-0.064x	+50.96%
2017-12-31	CN¥514.09 Million ≈ $75.23 Million	CN¥-67.18 Million ≈ $-9.83 Million	-0.131x	-225.46%
2016-12-31	CN¥300.40 Million ≈ $43.96 Million	CN¥31.29 Million ≈ $4.58 Million	0.104x	--

About Jiangsu Aidea Pharmaceutical Co Ltd

SHG:688488 China Biotechnology

Market Cap

$724.72 Million

CN¥4.95 Billion CNY

Market Cap Rank

#10031 Global

#2624 in China

Share Price

CN¥11.77

Change (1 day)

-1.92%

52-Week Range

CN¥11.09 - CN¥22.16

All Time High

CN¥42.39